UNSPSC 51393307: Etanterol

This classification denotes a bronchodilator with the molecular formula C18H24N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1597304395, chemically known as 5-amino-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)-m-xylene-alpha,alpha-diol but generally known as etanterol, which bears US NIH Compound Identifier 208937. European Medicines Agency schedules Etanterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07262MIG.

UNSPSC 51393307 Etanterol is a Commodity code for a pharmaceutical product with limited recent state and local procurement activity in the available record. The single recent opportunity shows Seminole County, Florida soliciting naloxone and drug deactivation systems through competitive bidding, indicating that state and local governments use this code—or codes closely aligned with it—to procure emergency medical and public health supplies, particularly those supporting harm reduction and community health initiatives. Issuing bodies appear to include county health departments and county procurement offices; the source provides insufficient evidence to characterize the broader issuing-body mix beyond this single county buyer.

Seminole County, Florida is the only jurisdiction with a recent opportunity in the source. The county released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, with a response deadline of July 26, 2023. The contract carries a two-year initial term with a one-year renewal option, fixed-fee pricing, E-Verify compliance and drug-free workplace certification requirements, and potential FEMA funding with associated federal compliance obligations. The source does not support characterization of geographic concentration, repeat-buyer patterns, or procurement frequency across multiple jurisdictions.